BTK and B-cell chronic lymphocytic leukemia: To confirm the direct involvement of BTK inhibition, we tested a more specific inhibitor namely acalabrutinib8 on 3 additional patients with CLL and we confirmed the increase in stiffness (P < 0.0001; Figure 4A).